Cipla launches Nintib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis
Cipla’s Nintib is priced at Rs 69 (100 mg) and Rs. 85 (150 mg) per capsule
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Nintedanib
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India
Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung…
Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic…